Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.46 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
| ▸ | PRKDC | P78527 | 10/20 | 0.38 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.36 |
| ▸ | ADK | P55263 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | TACR1 | P25103 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15430305 | 0.98 | ALOX5 (0.46) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL15430298 | 0.98 | ALOX5 (0.46) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL15430304 | 0.97 | ALOX5 (0.46) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL23866422 | 0.97 | ALOX5 (0.49) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL15430301 | 0.96 | ALOX5 (0.42) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL15430302 | 0.95 | ALOX5 (0.43) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL15430296 | 0.95 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL15430307 | 0.95 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL15430358 | 0.93 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL15430297 | 0.93 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2PRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140014930-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-01-16 | — | — | US | disclosed |
| US-20140014930-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-01-16 | — | — | US | disclosed |
| US-20070037979-A1 | Preparation of rosuvastatin | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037979-A1 | Preparation of rosuvastatin | HMGCR, PCSK9, PCSK7 | ALOX5 1278/4885GGPS1 8/4885PRKDC 2803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.